119 related articles for article (PubMed ID: 28655689)
1. Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method.
Madiha S; Tabassum S; Batool Z; Liaquat L; Sadir S; Shahzad S; Perveen T; Haider S
Pak J Pharm Sci; 2017 May; 30(3(Suppl.)):943-948. PubMed ID: 28655689
[TBL] [Abstract][Full Text] [Related]
2. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
[TBL] [Abstract][Full Text] [Related]
3. The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson's disease.
Troshev D; Berezhnoy D; Kulikova O; Abaimov D; Muzychuk O; Nalobin D; Stvolinsky S; Fedorova T
Brain Res Bull; 2021 Aug; 173():1-13. PubMed ID: 33892082
[TBL] [Abstract][Full Text] [Related]
4. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of motor and non-motor deficits and increased striatal APoE levels highlight the beneficial role of pistachio supplementation in rotenone-induced rat model of PD.
Haider S; Madiha S; Batool Z
Metab Brain Dis; 2020 Oct; 35(7):1189-1200. PubMed ID: 32529399
[TBL] [Abstract][Full Text] [Related]
6. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test.
Madiha S; Haider S
Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.
Khadrawy YA; Salem AM; El-Shamy KA; Ahmed EK; Fadl NN; Hosny EN
J Diet Suppl; 2017 Sep; 14(5):553-572. PubMed ID: 28301304
[TBL] [Abstract][Full Text] [Related]
8. Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration.
Morais LH; Lima MM; Martynhak BJ; Santiago R; Takahashi TT; Ariza D; Barbiero JK; Andreatini R; Vital MA
Pharmacol Rep; 2012; 64(5):1081-90. PubMed ID: 23238465
[TBL] [Abstract][Full Text] [Related]
9. Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson's disease in rotenone-treated rats.
Monir DM; Mahmoud ME; Ahmed OG; Rehan IF; Abdelrahman A
Behav Brain Funct; 2020 Nov; 16(1):9. PubMed ID: 33158454
[TBL] [Abstract][Full Text] [Related]
10. Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity.
Madiha S; Batool Z; Tabassum S; Liaquat L; Sadir S; Shahzad S; Naqvi F; Saleem S; Yousuf S; Nawaz A; Ahmad S; Sajid I; Afzal A; Haider S
PLoS One; 2021; 16(11):e0258928. PubMed ID: 34767546
[TBL] [Abstract][Full Text] [Related]
11. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.
Darbinyan LV; Hambardzumyan LE; Simonyan KV; Chavushyan VA; Manukyan LP; Badalyan SA; Khalaji N; Sarkisian VH
Metab Brain Dis; 2017 Dec; 32(6):1791-1803. PubMed ID: 28695411
[TBL] [Abstract][Full Text] [Related]
13. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish.
Wang Y; Liu W; Yang J; Wang F; Sima Y; Zhong ZM; Wang H; Hu LF; Liu CF
Neurotoxicology; 2017 Jan; 58():103-109. PubMed ID: 27866991
[TBL] [Abstract][Full Text] [Related]
15. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease.
Greene JG; Noorian AR; Srinivasan S
Exp Neurol; 2009 Jul; 218(1):154-61. PubMed ID: 19409896
[TBL] [Abstract][Full Text] [Related]
16. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
17. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
Sonia Angeline M; Sarkar A; Anand K; Ambasta RK; Kumar P
Neuroscience; 2013 Dec; 254():379-94. PubMed ID: 24070629
[TBL] [Abstract][Full Text] [Related]
18. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease.
Johnson ME; Stringer A; Bobrovskaya L
Neurotoxicology; 2018 Mar; 65():174-185. PubMed ID: 29471018
[TBL] [Abstract][Full Text] [Related]
19. Effect of lobeglitazone on motor function in rat model of Parkinson's disease with diabetes co-morbidity.
Hassanzadeh K; Rahimmi A; Moloudi MR; Maccarone R; Corbo M; Izadpanah E; Feligioni M
Brain Res Bull; 2021 Aug; 173():184-192. PubMed ID: 34051296
[TBL] [Abstract][Full Text] [Related]
20. Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats.
Yu JG; Wu J; Shen FM; Cai GJ; Liu JG; Su DF
J Pharmacol Sci; 2008 Sep; 108(1):56-62. PubMed ID: 18776711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
